FUNCTIONAL NEUROMODULATION
Functional Neuromodulation, a medical technology company, develops neuromodulation technologies for cognitive and memory disorders. It offers deep brain stimulation therapies for Alzheimer's disease and mild cognitive impairment. The company was founded in 2010 and is based in Toronto, Canada.
FUNCTIONAL NEUROMODULATION
Industry:
Developer Platform Health Care Medical
Founded:
2010-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.fxneuromod.com
Total Employee:
1+
Status:
Active
Contact:
434-242-0571
Total Funding:
10.4 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Genome
Genome is a biotechnology company developing and commercializing DNA sequencing technology.
Innovative Metabolics
Innovative Metabolics Inc., a Cambridge, Mass.-based developer of a neuron-modulation platform technology to treat a variety of acute.
Protagenic Therapeutics
Protagenic Therapeutics is a biotechnology company focusing on developing natural human brain hormones to treat mood disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Genesys Capital
Genesys Capital investment in Series A - Functional Neuromodulation
Medtronic
Medtronic investment in Series A - Functional Neuromodulation
Official Site Inspections
http://www.fxneuromod.com Semrush global rank: 8.65 M Semrush visits lastest month: 274
- Host name: alt2-w.exacthosting.com
- IP address: 173.199.142.212
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Functional Neuromodulation"
Functional Neuromodulation - Crunchbase Company …
Functional Neuromodulation, a medical technology company, develops neuromodulation technologies for cognitive and memory disorders. It offers deep brain stimulation therapies for Alzheimer's disease and mild cognitive …See details»
Functional Neuromodulation - LinkedIn
Functional Neuromodulation | 1,666 followers on LinkedIn. Functional Neuromodulation is advancing deep brain stimulation to treat mild Alzheimer's disease. | Functional …See details»
Functional Neuromodulation - PitchBook
Functional Neuromodulation General Information Description. Developer of neuromodulation technologies designed to treat Alzheimer's disease. The company's technologies use a …See details»
Functional Neuromodulation: Drug pipelines, Patents, Clinical trials ...
Explore Functional Neuromodulation with its drug pipeline, therapeutic area, technology platform, .See details»
Functional Neuromodulation - Craft
Functional Neuromodulation has 5 employees at their 1 location and $10.4 m in total funding,. See insights on Functional Neuromodulation including office locations, competitors, revenue, …See details»
Fxneuromod - CoBee Company Profile & Funding Rounds
Fxneuromod. FNM is a biotechnology company that develops deep brain stimulation therapies to treat people with Alzheimer disease.See details»
Functional Neuromodulation, Ltd. | VentureRadar
Similar Companies: CurvaFix USA Privately Held CurvaFix is a developer of medical devices to repair fractures in curved bones.. Scientia Vascular USA Privately Held Scientia Vascular, a …See details»
Functional Neuromodulation Ltd. | Insights
Jan 30, 2020 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Functional Neuromodulation Announces CEO Leadership Transition
Jan 25, 2019 Functional Neuromodulation Ltd. ("FNM" or the "Company"), a medical device company focused on bringing to market DBS-f, an implantable deep brain stimulation (DBS) …See details»
Functional Neuromodulation Announces CEO Leadership Transition
MINNEAPOLIS, Jan. 25, 2019 /PRNewswire/ -- Functional Neuromodulation Ltd. ("FNM" or the "Company"), a medical device company focused on bringing to market DBS-f, an implantable …See details»
Functional Neuromodulation Announces Breakthrough
Jan 6, 2021 For more information about the ADvance II Study, visit www.fxneuromod.com or www.advancestudy4ad.com. The clinical trial is currently enrolling subjects at 20 study sites …See details»
FUNCTIONAL NEUROMODULATION: Announces Breakthrough
Jan 8, 2021 Functional Neuromodulation announced today that it has received Breakthrough Device designation from the Center for Devices and Radiological Health (CDRH) of the U.S. …See details»
Using Electrical Stimulation For Alzheimer’s Disease
The ADvance II Study is researching the use of a surgically implanted device that delivers mild electrical pulses to specific areas of the brain in people with Alzheimer’s.See details»
Functional Neuromodulation Announces Breakthrough Device …
MINNEAPOLIS, Jan. 6, 2021 /PRNewswire/ -- Functional Neuromodulation announced today that it has received Breakthrough Device designation from the Center for Devices and Radiological …See details»
Functional Neuromodulation Announces CEO Leadership Transition
MINNEAPOLIS, Jan. 25, 2019 /PRNewswire/ -- Functional Neuromodulation Ltd. ('FNM' or the 'Company'), a medical device company focused on bringing ...See details»
Deep Brain Stimulation of the Fornix (DBSf) Shows Promise as …
Nov 6, 2015 More information about the company can be found at www.fxneuromod.com. 1 Humanitarian Device in the U.S.: The effectiveness of this device for the treatment of dystonia …See details»
DBS-f On and DBS Off in Alzheimer Disease - ICH GCP
Aug 1, 2018 The primary efficacy objective of this study is to test the hypothesis that DBS-f stimulation (ON) will slow cognitive and functional progression of AD, as compared to no …See details»
Functional Neuromodulation Initiates Pivotal Clinical Trial of Deep ...
MINNEAPOLIS, Sept. 10, 2019 /PRNewswire/ -- Functional Neuromodulation has initiated the global ADvance II Study, a pivotal clinical trial to assess deep brain stimulation (DBS) in …See details»
Advertising on Alzheimer’s & Dementia Weekly
Dec 31, 2020 Please let me know how I can best help your organization. All the best, Peter Berger Editor Alzheimer’s Weekly LLC 118-35 Queens Blvd, Suite 1620 ... Please reach out …See details»